Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Lupus nephritis
•
Systemic lupus erythematosus
•
Nephrology
Where do you introduce SGLT2 and GLP1 medications in the sequence of treatments for patients with lupus nephritis?
Related Questions
Do you favor obinutuzumab over voclosporin for patients with lupus nephritis and significant proteinuria and a history of non-adherence to medications?
Would you proceed with renal transplant in a patient with lupus nephritis who has progressed to ESRD and is clinically stable, but has persistently elevated dsDNA and low complements despite appropriate doses of hydroxychloroquine and mycophenolate?
Would you be comfortable combining rituximab with voclosporin in patients with lupus nephritis not responding to standard therapy?
What steroid regimen do you typically use for induction therapy in patients with lupus nephritis?
What factors do you consider when advising a patient with lupus nephritis on the safety of becoming pregnant?
What do you feel are the potential barriers to widespread use of obinutuzumab in proliferative lupus nephritis?
How would you approach a patient with class III and V lupus nephritis, already on HCQ, MMF, voclosporin and losartan, but has continued proteinuria not yet attaining complete renal response?
What are some practical tips for tacrolimus management/monitoring in SLE nephritis?
What factors do you weigh most heavily when choosing between belimumab and voclosporin as part of a triple therapy regimen for newly diagnosed class IV LN?
How do you treat a patient with new class V lupus nephritis and recent hx of breast cancer on tamoxifen?
